FDA Will Review Its Tobacco Division Due to PMTA-Related Criticism

Date:

As a result of the constant and relentless criticsm recived by it’s Center for Tobacco Products (CTP) over the way it has handled the ongoing PMTA process for vaping products, the head of the Food and Drug Administration (FDA), Robert Califf, announced he will be commissioning external experts to conduct “a comprehensive evaluation” of the center.

It is no secret that the FDA has been under scrutiny for multiple reasons related to the authorization of safer nicotine alternative products.

Last month the agency was heavily criticised by Senators Dick Durbin (D-Ill.) and Susan Collins (R-Maine). In a letter citing STAT’s reporting the agency’s lack of action with regards to a Synthetic Nicotine ban announced earlier this year, the Senators said that the FDA “appears to be on the brink of failing yet again at protecting our nation’s children.”

Similarly, president of the Campaign for Tobacco-Free Kids Matt Myers, highlighted that the FDA should exercise its authority to pull the products off the market. “All unauthorized synthetic nicotine products are now illegal and by law must be removed from the market now, not at some undetermined date in the future.”

Read full article here.

Diane Caruana – VapingPost – 2022-08-03.

Want More Investigative Content?

Curate RegWatch
Curate RegWatchhttps://regulatorwatch.com
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

MORE VAPING

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party